Top Markets
#1 MowCat MowCat +48.51%
#2 Bitway Bitway +28.60%
#3 Velvet Velvet +25.02%
#4 Fake World Assets Fake World Assets +24.70%
#5 aPriori aPriori +24.35%
#6 OVERTAKE OVERTAKE +20.74%
#7 Zerebro Zerebro +17.04%
#8 Verus Coin Verus Coin +16.08%
#9 Derive Derive +14.93%
#10 Biconomy Biconomy +13.92%
Coin of the day
MowCat MowCat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Hainan Poly Pharm. Co., Ltd Hainan Poly Pharm. Co., Ltd

Hainan Poly Pharm. Co., Ltd

300630
Rangering i aksjer #34414
Hainan Poly Pharm. Co., Ltd. operates as a pharmaceutical enterprise in China,... Hainan Poly Pharm. Co., Ltd. operates as a pharmaceutical enterprise in China, engaging in the full spectrum of activities from research and development to the production and distribution of medicinal products. The company supplies Active Pharmaceutical Ingredients (APIs) and also manufactures a diverse array of finished drug formulations. These therapeutic preparations cater to various medical needs, including anti-allergy, non-steroidal anti-inflammatory, antibiotic, and digestive conditions. Key products within their portfolio include desloratadine preparations for anti-allergy treatment, diclofenac formulations for anti-inflammatory relief, azithromycin for injection and clarithromycin preparations as antibiotics, and trimebutine maleate for digestive health. Established in 1992, the company is headquartered in Haikou, China.
Aksjekurs
$0.12353728
Sist synkronisert: 2025-05-22
Markedsverdi
$5.65M
Endring (1 dag)
-4.21%
Endring (1 år)
0.00%
Land
CN
Handel Hainan Poly Pharm. Co., Ltd (300630)

Kategori

Healthcare
Inntekter for Hainan Poly Pharm. Co., Ltd (300630)
Inntekter i 2026 TTM: 0
Ifølge Hainan Poly Pharm. Co., Ltd sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Hainan Poly Pharm. Co., Ltd fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
$1.76B -
IN